SEC 13F Intelligence

Knoll Capital Management, LLC / KRYS

Knoll Capital Management, LLC’s Krystal Biotech Inc Position

Does Knoll Capital Management, LLC own Krystal Biotech Inc (KRYS)? Not currently — the last reported position was 120.2K shares worth $4M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q3 2019
Shares
120.2K
% of Portfolio
+3.82%
Quarters Held
4
position exited

Position History KRYS

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $7MQ1 ’19Q2 ’19: $6MQ2 ’19Q3 ’19: $4MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019120.2K$4M+3.82%
Q2 2019147.1K$6M+4.85%
Q1 2019210.0K$7M+5.25%
Q4 2018300.0K$6M+7.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Knoll Capital Management, LLC’s full portfolio or all institutional holders of KRYS.